Information displayed below is a subset of the entire knowledge base and may be incomplete intensionally or inadvertently. If you detect a serious error or want access to the complete knowledge base, please contact us.

Description

Afimoxifene (INN) is a selective estrogen receptor modulator (SERM) that was developed as a potential treatment for breast cancer. It is a non-steroidal compound that binds to the estrogen receptor and has both estrogenic and anti-estrogenic effects. It has been studied for its potential to reduce the risk of breast cancer recurrence in postmenopausal women.

Toxic effects of afimoxifene include nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, fatigue, and hot flashes. It may also cause an increased risk of blood clots, stroke, and endometrial cancer.

Associated brand names:
  ▸ Afinitor
  ▸ Afinitor Disperz
  ▸ Votubia

Synonyms

• afimoxifene

Classifications

• selective estrogen receptor modulator
• sport doping

Detailed Disease Information (use the search buttons below to find details on these topics from other web sources)
All of the following must be considered when interpreting clinical findings and are too extensive to be covered on this site: